Spirulina platensis as a Natural Antileishmanial Candidate: Effective Inhibition of LRV2+ and LRV2− Leishmania major Isolates In Vitro

  • Mahya Allahmoradi Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Homa Hajjaran Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Zahra Mirabedini Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Hamed Mirjalali Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Mehdi Mohebali Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Behnam Mohammadi-Ghalehbin Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
Keywords: Leishmania major; Herbal medicine; Spirulina platensis (Arthrospira platensis); Leishmania RNA virus 2

Abstract

Background: Drug resistance and treatment failure in Leishmania infections are major concerns. Leishmania RNA virus 2 (LRV2) enhances host inflammation, indirectly favoring the parasite. Thus, alternative treatments are needed. Spirulina platensis has shown antimicrobial potential.

Methods: The alcoholic extract of S. platensis was tested against L. major with or without LRV2. Anti-promastigote activity was evaluated directly on parasites, cytotoxicity on J774.A1 macrophages, and anti-amastigote effects using the MTT assay.

Results: The extract showed significant, dose-dependent anti-leishmanial activity against both LRV2+ and LRV2− promastigotes (IC₅₀ = 62.5 μg/mL). J774.A1 cells remained viable at 62.5–2000 μg/mL (P = 0.0005). Amastigote growth was inhibited at 1000 and 2000 μg/mL in both strains.

Conclusion: S. platensis extract exhibits strong anti-leishmanial activity and low cytotoxicity, suggesting its potential as a natural therapeutic candidate against L. major, irrespective of LRV2 status. Further in vivo studies are warranted.

Published
2025-12-16
Section
Articles